Two Sigma Advisers LP boosted its holdings in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 823.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 739,522 shares of the medical equipment provider’s stock after purchasing an additional 659,412 shares during the quarter. Two Sigma Advisers LP’s holdings in Zimmer Biomet were worth $89,238,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Jones Financial Companies Lllp acquired a new stake in Zimmer Biomet in the 4th quarter valued at $323,000. Teachers Insurance & Annuity Association of America purchased a new position in Zimmer Biomet during the 4th quarter worth $626,000. HPM Partners LLC boosted its holdings in Zimmer Biomet by 4.2% during the 4th quarter. HPM Partners LLC now owns 11,958 shares of the medical equipment provider’s stock worth $1,443,000 after acquiring an additional 484 shares during the last quarter. Stone Ridge Asset Management LLC purchased a new position in Zimmer Biomet during the 4th quarter worth $302,000. Finally, Guggenheim Capital LLC boosted its holdings in Zimmer Biomet by 14.8% during the 4th quarter. Guggenheim Capital LLC now owns 458,495 shares of the medical equipment provider’s stock worth $55,326,000 after acquiring an additional 58,941 shares during the last quarter. 86.64% of the stock is owned by institutional investors and hedge funds.
In related news, VP Chad F. Phipps sold 20,826 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $115.95, for a total value of $2,414,774.70. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Bryan C. Hanson acquired 25,077 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was purchased at an average price of $119.68 per share, for a total transaction of $3,001,215.36. The disclosure for this purchase can be found here. Insiders own 1.07% of the company’s stock.
Shares of Zimmer Biomet Holdings Inc (ZBH) opened at $117.92 on Wednesday. The company has a market capitalization of $24,024.15, a price-to-earnings ratio of 14.73, a PEG ratio of 2.06 and a beta of 1.13. Zimmer Biomet Holdings Inc has a 52 week low of $108.03 and a 52 week high of $133.49. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.81 and a current ratio of 1.50.
Zimmer Biomet (NYSE:ZBH) last released its earnings results on Tuesday, January 30th. The medical equipment provider reported $2.10 EPS for the quarter, hitting the Zacks’ consensus estimate of $2.10. The company had revenue of $2.07 billion for the quarter, compared to analysts’ expectations of $2.03 billion. Zimmer Biomet had a return on equity of 15.45% and a net margin of 23.51%. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.14 EPS. research analysts predict that Zimmer Biomet Holdings Inc will post 7.8 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Wednesday, March 28th. Zimmer Biomet’s payout ratio is 10.65%.
ILLEGAL ACTIVITY WARNING: “Two Sigma Advisers LP Boosts Position in Zimmer Biomet Holdings Inc (ZBH)” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3261890/two-sigma-advisers-lp-boosts-position-in-zimmer-biomet-holdings-inc-zbh.html.
Zimmer Biomet Company Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.